Minnesota

Showing 1-9 of 9 grants

Title	Institution	Researcher	Program	Duration	Total Award Amount
Growing Beta Cell Replacement in T1D by Tolerizing Stem Cell-Derived Islets	Regents of the University of Minnesota	Bernhard Hering	Cures	01-August-2025 to 31-July-2027	$688.430,02
Optimizing islet cell graft performance with targeted alpha and beta cell composition and distribution	Mayo Clinic	Quinn Peterson	Cures	01-April-2025 to 31-March-2027	$699.138,64
Employing PD-L1-Modified Biomaterials to Induce Islet Allograft Tolerance Following Perihepatic Transplantation in Nonhuman Primates	Regents of the University of Minnesota	Melanie Graham	Cures	01-April-2025 to 31-March-2027	$918.744,88
Determining how frequent infections alter autoreactive T-cell fates and type 1 diabetes risk	Regents of the University of Minnesota	Zachary Shaheen	Cures	01-June-2024 to 31-May-2025	$199.890,00
Mechanistic Etiologies Underlying the Impact of Verapamil to Preserve β Cell Function in Type 1 diabetes	Regents of the University of Minnesota	Antoinette Moran	Cures	01-September-2024 to 31-August-2026	$643.946,00
Hybrid Closed Loop Therapy for Beta Cell Preservation in New Onset Type 1 Diabetes (CLVer): Extension Study (CLVerEX)	Regents of the University of Minnesota	Antoinette Moran	Cures	01-April-2023 to 31-March-2026	$1.739.442,00
Assessment of Beta Cell Small Extracellular Vesicles in the Pathogenesis of Type 1 Diabetes	Mayo Clinic	Naureen Javeed	Cures	01-September-2022 to 31-August-2025	$400.000,00
Preclinical development of a combinatorial therapy with a humanized antibody to serpinB13 in type 1 diabetes	Regents of the University of Minnesota	Jan Czyzyk	Cures	01-June-2022 to 31-May-2025	$765.000,00
Colonic Delivery of Butyrate to Improve Insulin Sensitivity and Lower Triglycerides in Type 1 Diabetes Patients	Mayo Clinic	Adrian Vella	Improving Lives	01-October-2019 to 31-March-2025	$437.405,39